Incidence of temonera, sulphuhydryl variables and cefotaximase genes associated with β-lactamase producing escherichia coli in clinical isolates

North American Journal of Medical Sciences

Volumn 3, Issue 12, 2011, Pages 557-561

  Isaiah, Ibeh Nnana ^a   Nche, Bikwe Thomas ^b   Nwagu, Ibeh Georgina ^b   Nwagu, Ibeh Isaiah ^b  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Bla TEM; Cephalosporins; Extended spectrum beta lactamase; SHV and CTX M

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL ENZYME; CEFOTAXIMASE; CEFOTAXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; TEMONERA; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; CTX M GENE; ESCHERICHIA COLI; FECES; GENE; HOSPITAL PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; SHV GENE; TEM GENE; URINE; WOUND;

EID: 84255162191     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.3554     Document Type: Article

References (30)

1. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE JR, Gaynes RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998; 19: 388-394.
2. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589-603.
3. Iroha IR, Egwu OA, Ngozi AT, Chidiebube NA, Chika EP.Extended spectrum beta-lactamase (ESBL) mediated resistance to antibiotics among Klebsiella pneumoniae in enugu Metropolis. Maced J Med Sci 2009; 2:196-199.
4. Paterson DL, Ko WC, Von Gottberg A, al. Implications of extendedspectrum beta-lactamase production in nosocomial infections international prospective study of Klebsiella pneumoniae bacteremia. Ann Intern Med 2004; 140:26-32.
5. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M β-Lactamases produced by Escherchia coli and Klebsiella spp. J Clin Microbiol 2004; 42:5715-5721.
6. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases.: a clinical update. Clin Microbiol Rev 2005; 18:657-686.
7. Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV Beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 2007; 13:247-250.
8. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 2006; 12: BR362-5.
9. Aminzadeh Z, Sadat Kashi M, Sha'bani M. Bacteriuria by extended-spectrum Beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis 2008; 2: 197-200.
10. Ramazanzadeh R, Chitsaz M, Bahmani N. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing bacteria in intensive care units of Sanandaj general hospitals (Kurdistan, Iran). Chemothe 2009; 55: 287-292.
11. Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran. Acta Microbiol Immunol Hung 2009; 56:89-99.
12. Feizabadi MM, Delfani S, Raji N, et al. Distribution of bla(TEM) bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad hospital, Tehran, Iran. Microb Drug Resist 2010;16:49-53.
13. Podschun R, Ullmann U. Klebsiella spp as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589-603.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved Standard M2-A8. NCCLS, Villanova: PA, USA: 2004.
15. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial nsusceptibility tests for bacteria that grow aerobically. 5thed. Approved document M7-A5. Wayne, PA, USA, 2000.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing.15th informational supplement (M100-s15) NCCLS.
17. Johnson A, Woodford N. Plasmid analysis. In: Johnson A, Woodford P, eitords. Molecular bacteriology protocols and clinical application. London: Human Press; 1998.p.24-28.
18. Branger C, Lesimple AL, Bruneau B, Berry P, Lambert-Zechovsky N. Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases in a university hospital. J Med Microbiol 1998; 47: 201-209.
19. Mendes C, Kiffer C, Segura A, Ribeiro J, Turner P. Klebsiella pneumoniae with multiple antimicrobial resistances. Braz J Infect Dis 2004; 8:109-111.
20. Putman M, VanVeen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbial Mol Biol Rev 2000; 64:672-693.
21. Silva1 N, Oliveira M, Bandeira1 AC, Brites C. Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a Tertiary hospital in Salvador, Brazil. Braz J Infect Dis 2006; 10:191-193.
22. Jeong SH, Bae IK, Lee JH, et al. Molecularcharacterization of extended spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004; 42: 2902-2906.
23. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM and SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 2007; 125: 173-8.
24. Taşli H, Bahar IH. Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based enterobacteriaceae in Turkey. Jpn J Infect Dis 2005; 58:162-167.
25. Pages JM, Lavigne JP, Leflon-Guibout V, et al. Efflux pump, the masked side of ß-Lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS One 2009; 4:e4817.
26. Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol 2005; 23:20-23.
27. Nathisuwan S, Burgess DS. Extended-spectrum beta-lactamases: epidemiology, detection, and treatment. Pharmacother 2001; 21:920-928.
28. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33:1288-1294.
29. Olson AB, Silverman M, Boyd DA, et al. Identification of a progenitorof the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob Agents Chemother 2005; 49:2112-2115.
30. Bernard H, Tancrede C, Livrelli V, Morand A, Barthelemy M, Labia R. A novel plasmid-mediatedextended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes. J Antimicrob Chemother 1992; 29:590-592.